Page last updated: 2024-08-23

radium and Prostatic Neoplasms

radium has been researched along with Prostatic Neoplasms in 144 studies

Research

Studies (144)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (10.42)	18.7374
1990's	2 (1.39)	18.2507
2000's	5 (3.47)	29.6817
2010's	107 (74.31)	24.3611
2020's	15 (10.42)	2.80

Authors

Authors	Studies
O'Sullivan, JM	1
Fujii, Y; Hinotsu, S; Izumi, K; Kimura, G; Mizokami, A	1
De Vincentis, G; Frantellizzi, V; Pani, A; Pani, R; Pontico, M	1
Connor, MJ; Hattangadi-Gluth, JA; Huynh-Le, MP; Shults, RC	1
Bruland, ØS; Juzeniene, A; Larsen, RH; Stenberg, VY	1
Antonarakis, ES; Caldwell, T; Carducci, MA; Deek, MP; Denmeade, S; Deville, C; DeWeese, TL; Dipasquale, S; Dudley, S; Eisenberger, MA; Gorin, MA; Greco, SC; Hasan, H; Hobbs, RF; Huang, J; Kiess, AP; Leitzel, J; Malek, R; Markowski, M; Paller, CJ; Phillips, R; Pienta, KJ; Pomper, MG; Powell, J; Radwan, N; Rowe, SP; Song, DY; Thompson, E; Tran, PT; Wang, H; Wendler, D	1
Casarin, S; Dondossola, E	1
Etchebehere, E; Lima, M; Minekawa, T; Moraes, A; Santos, A	1
Fukae, S; Hongo, S; Kondoh, F; Okumi, M; Shimo, T; Soda, T; Takada, S; Yamamoto, A; Yoshioka, I; Yoshitome, K	1
Abouassaly, R; Bryk, DJ; Ericson, K; Fascelli, M; Haywood, SC; Khanna, A; Murthy, PB; O'Connor, LP; Yerram, NK	1
Akakura, K; Kitoh, H; Kurosaki, H; Miura, K; Utsumi, N	1
Corn, P; Efstathiou, E; Gallick, GE; Gentile, E; Guerra, L; Hoang, A; Lee, YC; Lin, SC; Lin, SH; Logothetis, CJ; Madan, N; Melancon, MP; Navone, N; Panaretakis, T; Parikh, N; Santos, E; Song, JH; Subudhi, SK; Troncoso, P; Vardaki, I; Yu, G	1
Damasco, JA; Heralde, FM; Lin, SC; Lin, SH; Melancon, MP; Novone, NM; Perez, JVD; Rojo, RD; Santos, EB; Yu, G	1
Devos, G; Everaerts, W; Goffin, K; Joniau, S; Pans, S; Schillebeeckx, L; Tosco, L; Van Poppel, H	1
Biggart, S; Cole, A; Grey, A; Hounsell, AR; Jain, S; McGarry, CK; Mitchell, D; O'Sullivan, JM; Prise, KM; Turner, PG	1
Strane, T	1
Agarwal, N; Boucher, K; Haaland, B; Hahn, AW; Hoffman, JM; Kessel, A; Kohli, M; Maughan, BL; McFarland, TR; Morton, K; Nussenzveig, R; Sayegh, N; Sirohi, D; Swami, U	1
Albert, NL; Bartenstein, P; Fendler, WP; Gratzke, C; Herlemann, A; Ilhan, H; la Fougère, C; Rominger, A; Stief, CG; Tirichter, N; Wenter, V	1
Saad, F; Traboulsi, SL	1
Flux, GD	1
Aupee, O; Bertolaso, P; Cazeau, AL; Gross-Goupil, M; Le Moulec, S; Leroy, L; Ravaud, A; Roubaud, G	1
Baka, A; de Meijer, C; Gaultney, JG; Leliveld-Kors, AM; Noordzij, W; Peters, ML; van den Berg, PH; van den Bosch, J; Wyndaele, D	1
De Bono, J; Sumanasuriya, S	1
Fukai, S; Koizumi, M; Miyaji, N; Motegi, K; Nakazawa, S; Takiguchi, T; Umeda, T	1
Azuma, H; Ibuki, N; Inamoto, T; Kantoff, PW; Komura, K; Sweeney, CJ	1
Barsanti, R; Zustovich, F	1
Abrahamsson, M; Falkenius, J; Henriksson, R; Lindquist, M; Lööv, SÅ; Norin, S; Öhman, D	1
Gourd, E	1
Wei, ZF; Xu, XF; Zhang, ZY	1
Baumgart, SJ; Haendler, B; Nevedomskaya, E	1
Bruland, ØS; Herlofson, BB; Kjølle, GK; Løndalen, AM; Westgaard, KL	1
Canelón Castillo, E; Díez Farto, S; Jiménez Romero, ME; Navarro Serrato, JS; Revelo Cadena, I	1
Garla, VV; Kovvuru, KR; Salim, S; Subauste, A	1
Ferretti, A; Gross, MD; Rubello, D; Viglianti, BL; Wale, DJ; Wong, KK	1
Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K	1
Casarin, S; De-Juan-Pardo, EM; Dondossola, E; Friedl, P; Hutmacher, DW; Logothetis, CJ; Paindelli, C	1
Dondossola, E; Friedl, P; Logothetis, CJ; Navone, N; Paindelli, C	1
Beaumont, JL; Butt, Z; Cella, D; Li, R	1
Spratt, DE	1
Buonerba, C; Di Lorenzo, G; Fizazi, K; Pagliuca, M	1
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Nava-Cabrera, MA; Rojas-Calderón, E	1
Carolino, E; Dizdarevic, S; Gape, P; Jessop, M; Pereira, L; Roque, V; Sousa, E	1
Leibowitz-Amit, R	1
Aro, JL; Dinning, SI; Leung, EY; Zuckier, LS	1
Braune, A; Freudenberg, R; Grosche-Schlee, S; Kotzerke, J; Oehme, L; Runge, R	1
Kantoff, PW; Mohler, JL	1
Kellokumpu-Lehtinen, P; Tammela, T	1
Boehmer, S; Bottomley, D; Bruland, ØS; Chodacki, A; Coleman, R; Dall'Oglio, M; Fosså, SD; Franzén, L; Garcia-Vargas, J; Heinrich, D; Helle, SI; Hoskin, P; James, ND; Johannessen, DC; Kliment, J; Logue, J; Nilsson, S; O'Bryan-Tear, CG; O'Sullivan, JM; Parker, C; Sartor, O; Seke, M; Shan, M; Solberg, A; Staudacher, K; Syndikus, I; Vogelzang, NJ; Wedel, S; Widmark, A; Wiechno, P	1
Glatstein, E; Vapiwala, N	2
Colletti, PM	1
Ha, YS; Joung, JY; Kim, IY	1
McBride, D	1
Gelderblom, H; van der Pluijm, G; van Leeuwen, FW; Wissing, MD	1
Grivas, PD; Keller, ET	1
Parker, C; Sartor, O	2
Biersack, HJ; Ezziddin, S; Knapp, FF	1
Ciezki, JP; Klein, EA; Tendulkar, RD; Ward, MC	1
Bastide, C; Beuzeboc, P; Brenot-Rossi, I; Bruyère, F; Guy, L; Karsenty, G; Mongiat-Artus, P	1
Armstrong, AJ; Bahnson, RR; Cohen, M; D'Amico, AV; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Ho, M; Horwitz, EM; Kantoff, PW; Kawachi, MH; Kuettel, M; Lee, RJ; Macvicar, GR; Malcolm, AW; Miller, D; Mohler, JL; Plimack, ER; Pow-Sang, JM; Richey, S; Roach, M; Rohren, E; Rosenfeld, S; Shead, DA; Small, EJ; Srinivas, S; Stein, C; Strope, SA; Tward, J; Walsh, PC	1
D'Amico, AV	1
Giammarile, F	1
Taneja, SS	1
Higano, CS	1
Vogelzang, NJ	1
Roach, M	1
Sartor, O	2
Gartrell, BA; Saad, F	1
O'Sullivan, J; Turner, PG	1
Géczi, L; Sinkovics, I	1
Buxbaum, S; Decristoforo, C; Horninger, W; Kroiss, A; Nilica, B; Uprimny, C; Virgolini, IJ	1
Bjøro, T; Bogsrud, TV; Fosså, SD; Hernes, E; Nome, R	1
Bilusic, M; Chen, D; Ito, T	1
Coleman, R; Efstathiou, E; Fizazi, K; Gartrell, BA; Logothetis, CJ; Saad, F; Sartor, O; Smith, MR; Sonpavde, G	1
Chalhoub, E; Chalouhy, C; Lewis, B; Sartor, O	1
Bilen, MA; Lin, SH; Tu, SM	1
Bienz, M; Saad, F	1
Chowdhury, S; Gilson, C; Kirby, R; Manickavasagar, T	1
Araujo, JC; Erwin, WD; Etchebehere, EC; Fox, P; Macapinlac, HA; Milton, DR; Rohren, EM; Swanston, NM; Wendt, RE	1
Shore, ND	1
Dermine, A; Machiels, JP	1
Ahmadzadehfar, H; Essler, M; Rogenhofer, S; Schlenkhoff, CD; Yordanova, A	1
García-Pérez, FO; Medina-Ornelas, SS	1
Dahut, WL; Gulley, JL; Madan, RA	1
Thoma, C	1
Edwards, CM; Turner, CJ	1
Ahmadzadehfar, H; Azgomi, K; Essler, M; Gaertner, FC; Hauser, S; Kürpig, S; Strunk, H; Wei, X; Yordanova, A	1
Bolton, D; Corfield, J; Crozier, J; Joshua, AM; Lawrentschuk, N	1
Cotogno, P; Ledet, EM; Lewis, B; Sartor, O; Steinberger, AE	1
Miyahira, AK; Morris, M; Soule, HR	1
Nilsson, S	1
Bögemann, M; Bräuer, A; Konnert, J; Rahbar, K; Stegger, L	1
Alibhai, SMH; Emmenegger, U; Finelli, A; Hotte, SJ; Morgan, SC; Walker-Dilks, C; Winquist, E; Zukotynski, K	1
DARGET, R	5
Kamoto, T	1
Agarwal, N; Sonpavde, G; Sternberg, CN	1
Aksnes, AK; Andersson, C; Bruland, ØS; Franzèn, L; Nilsson, S; Olivier, P; Pecking, A; Staffurth, J; Strang, P; Vasanthan, S	1
Lewis, B; Sartor, O	1
Mackiewicz-Wysocka, M; Pankowska, M; Wysocki, PJ	1
Beuzeboc, P; Goldwasser, F; Ropert, S; Zerbib, M	1
Cheetham, PJ; Petrylak, DP	1
Chang, AJ; Roach, M	1
Silberstein, EB	1
O'Sullivan, JM; Parker, CC; Vengalil, S	1
Chodacki, A; Germá, JR; Haider, T; Hoskin, P; O'Bryan-Tear, CG; O'Sullivan, JM; Parker, CC; Pascoe, S	1
Blom, R; Bolstad, B; Bruland, ØS; Franzén, L; Johannessen, DC; Lennernäs, B; Nilsson, S; O'Bryan-Tear, CG; Parker, C; Petersson, U; Pigott, K; Sokal, M; Tennvall, J; Thuresson, M; Tyrrell, C	1
Lassmann, M; Nosske, D	1
Bellmunt, J	1
Lewis, B; Pal, SK; Sartor, O	1
Croke, J; Leung, E; Malone, S; Segal, R	1
Cruz, P; Pinto, A	1
Armstrong, AJ; Fizazi, K; Freedland, S; Pienta, K; Saad, F; Saylor, PJ; Smith, MR; Tombal, B	1
Arazi, L; Cooks, T; Efrati, M; Etzyoni, R; Keisari, Y; Kelson, I; Lazarov, E; Raab, S; Reitkopf, S; Schmidt, M; Tal, M	1
Culine, S; Ouzaid, I; Pouessel, D; Ravery, V	1
Hafeez, S; Parker, C	1
SMITH, GG	1
BURCHAM, TA; CULP, DA; HENDRICKSON, FR; KINSELEY, RM; PETERSON, RE	1
MALIPHANT, RG	1
Balteskard, L; Borch, KW; Bruland, OS; Fosså, SD; Larsen, RH; Nilsson, S; Salberg, G; Westlin, JE	1
Altavilla, G; Aricò, D; Baldari, S; Herberg, A; Minutoli, F; Restifo Pecorella, G; Spadaro, P	1
Bruland, ØS; Fisher, DR; Larsen, RH; Nilsson, S	1
Blom, R; Bolstad, B; Bruland, OS; Franzén, L; Garkavij, M; Harmenberg, J; Johannessen, DC; Lennernäs, B; Nilsson, S; Parker, C; Petersson, U; Pigott, K; Sokal, M; Strang, P; Tennvall, J; Tyrrell, C; Yachnin, J	1
Mason, MD; Shelley, MD	1
DUVERGEY, H	1
Ballanger, P; Ballanger, R	1
Inoue, T	1
Perez, CA	1
Piller, S	1
Friedman, DB; Hébert, JR; Owens, OL; Thomas, TL	1
CHARKES, ND; SKLAROFF, DM	1
Stephens, B	1

Reviews

45 review(s) available for radium and Prostatic Neoplasms

Article	Year
Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective. Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1 Topics: Alpha Particles; Humans; Male; Prostatic Neoplasms; Radiation Oncology; Radioisotopes; Radium	2019
Contemporary management of advanced prostate cancer: an evolving landscape. Clinical advances in hematology & oncology : H&O, 2021, Volume: 19, Issue:2 Topics: Adenocarcinoma; Androstenes; Benzamides; Clinical Trials as Topic; Combined Modality Therapy; Diagnostic Imaging; Disease Management; Docetaxel; Humans; Male; Multicenter Studies as Topic; Nitriles; Phenylthiohydantoin; Precision Medicine; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radiotherapy, Adjuvant; Radium; Taxoids; Therapies, Investigational	2021
The role of bone-targeted therapies for prostate cancer in 2017. Current opinion in supportive and palliative care, 2017, Volume: 11, Issue:3 Topics: Androstenes; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Male; Prospective Studies; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Zoledronic Acid	2017
Imaging and dosimetry for radium-223: the potential for personalized treatment. The British journal of radiology, 2017, Volume: 90, Issue:1077 Topics: Bone Neoplasms; Humans; Male; Precision Medicine; Prostatic Neoplasms; Radioisotopes; Radiometry; Radium	2017
[Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts]. Bulletin du cancer, 2017, Volume: 104, Issue:9 Topics: Alpha Particles; Beta Particles; Bone Neoplasms; Cancer Pain; Clinical Trials as Topic; Gamma Rays; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2017
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise. Cold Spring Harbor perspectives in medicine, 2018, 06-01, Volume: 8, Issue:6 Topics: Androgen Receptor Antagonists; Androstenes; Antigens, Surface; Benzamides; Bridged-Ring Compounds; Drug Discovery; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Receptors, Androgen; Taxoids; Tissue Extracts	2018
Current treatment strategies for advanced prostate cancer. International journal of urology : official journal of the Japanese Urological Association, 2018, Volume: 25, Issue:3 Topics: Algorithms; Antineoplastic Agents; Biomarkers, Tumor; Cancer Vaccines; Humans; Male; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium; Tissue Extracts	2018
Targeted α Therapies for the Treatment of Bone Metastases. International journal of molecular sciences, 2017, Dec-28, Volume: 19, Issue:1 Topics: Alpha Particles; Bone Neoplasms; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Male; Practice Guidelines as Topic; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic	2017
[Radium-223 for the treatment of bone metastasis of prostate cancer]. Zhonghua nan ke xue = National journal of andrology, 2017, Volume: 23, Issue:1 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radium	2017
Recent Advances in Prostate Cancer Treatment and Drug Discovery. International journal of molecular sciences, 2018, May-04, Volume: 19, Issue:5 Topics: Abiraterone Acetate; Androgen Receptor Antagonists; Antigens, Surface; Benzamides; Drug Discovery; Glutamate Carboxypeptidase II; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prostate; Prostatic Neoplasms; Radioisotopes; Radium; Receptors, Androgen; Thiohydantoins	2018
Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma. American journal of clinical oncology, 2019, Volume: 42, Issue:1 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Lutetium; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium	2019
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 2018, Volume: 13, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium	2018
The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer. Drugs, 2019, Volume: 79, Issue:4 Topics: Androgen Antagonists; Androstenes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Benzamides; Clinical Trials as Topic; Docetaxel; Humans; Immunotherapy; Male; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Retrospective Studies; Taxoids; Thiohydantoins; Tissue Extracts	2019
Safe Use of Radium-223 Dichloride ( Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Exposure; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Safety Management; Tissue Distribution	2019
New developments in the management of prostate cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 2013, Volume: 11, Issue:5 Suppl Topics: Androgens; Antineoplastic Agents; Bone Neoplasms; Humans; Immunotherapy; Male; Prostatic Neoplasms; Radioisotopes; Radium; Salvage Therapy; Signal Transduction	2013
[Novel drugs provide better therapy for prostate cancer]. Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:9 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Denosumab; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids	2013
Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-01, Volume: 19, Issue:21 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Drug Approval; Drug Evaluation, Preclinical; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium	2013
Future directions from past experience: a century of prostate radiotherapy. Clinical genitourinary cancer, 2014, Volume: 12, Issue:1 Topics: Bone Neoplasms; Brachytherapy; History, 20th Century; History, 21st Century; Humans; Male; Prostate; Prostatic Neoplasms; Proton Therapy; Radioisotopes; Radiotherapy, Adjuvant; Radium; Salvage Therapy	2014
[The non-hormonal treatment of metastatic prostate cancer]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Density Conservation Agents; Cisplatin; Denosumab; Docetaxel; Etoposide; Humans; Male; Mitoxantrone; Organometallic Compounds; Organophosphorus Compounds; Osteoporosis; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radium; RANK Ligand; Strontium; Strontium Radioisotopes; Taxoids	2013
[Bone metastases treated with radiopharmaceuticals]. Bulletin du cancer, 2013, Volume: 100, Issue:11 Topics: Analgesics; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Strontium; Strontium Radioisotopes	2013
Pathologic fracture in patients with metastatic prostate cancer. Current opinion in urology, 2014, Volume: 24, Issue:6 Topics: Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Zoledronic Acid	2014
[Bone-targeted treatment in prostate cancer]. Magyar onkologia, 2014, Volume: 58, Issue:3 Topics: Alkaline Phosphatase; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic; RANK Ligand; Treatment Outcome	2014
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options. European urology, 2015, Volume: 68, Issue:5 Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Prostatic Neoplasms; Radioisotopes; Radium; Zoledronic Acid	2015
Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:7 Topics: Alkaline Phosphatase; Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Radium	2015
Management of bone metastases in prostate cancer: a review. Current opinion in supportive and palliative care, 2015, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Zoledronic Acid	2015
Treatment landscape of metastatic prostate cancer: the role of radium-223. Acta clinica Belgica, 2017, Volume: 72, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium	2017
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease. Current osteoporosis reports, 2016, Volume: 14, Issue:5 Topics: Adipocytes; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Bone and Bones; Bone Density Conservation Agents; Bone Marrow Cells; Bone Neoplasms; Carcinoma; Denosumab; Diphosphonates; Humans; Male; Mesenchymal Stem Cells; Molecular Targeted Therapy; Osteoblasts; Osteoclasts; Prostatic Neoplasms; Radioisotopes; Radium; Tumor Microenvironment	2016
Understanding the role of new systemic agents in the treatment of prostate cancer. BJU international, 2016, Volume: 118 Suppl 3 Topics: Abiraterone Acetate; Antineoplastic Agents, Hormonal; Docetaxel; Humans; Immunotherapy; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Precision Medicine; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Taxoids; Tissue Extracts	2016
Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223. The Prostate, 2017, Volume: 77, Issue:3 Topics: Bone Neoplasms; Clinical Trials as Topic; Congresses as Topic; Foundations; Humans; Male; New York City; Prostatic Neoplasms; Radioisotopes; Radium; Research Report	2017
Radium-223 Therapy of Bone Metastases in Prostate Cancer. Seminars in nuclear medicine, 2016, Volume: 46, Issue:6 Topics: Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Humans; Male; Prostatic Neoplasms; Radium	2016
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline. Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, Volume: 29, Issue:6 Topics: Absorptiometry, Photon; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Zoledronic Acid	2017
[Encounter of cancer cells with bone. Management of bone metastasis arising from prostate cancer]. Clinical calcium, 2011, Volume: 21, Issue:3 Topics: Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Evidence-Based Medicine; Humans; Imidazoles; Male; Molecular Targeted Therapy; NF-kappa B; Prostatic Neoplasms; Radioisotopes; Radium; Receptor Activator of Nuclear Factor-kappa B; Strontium; Zoledronic Acid	2011
Novel molecular targets for the therapy of castration-resistant prostate cancer. European urology, 2012, Volume: 61, Issue:5 Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic	2012
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Humans; Male; Pain; Palliative Care; Prostatic Neoplasms; Radium; Survival Analysis	2012
Progress in the treatment of bone metastases in cancer patients. Expert opinion on investigational drugs, 2012, Volume: 21, Issue:6 Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Humans; Male; Prostatic Neoplasms; Quality of Life; Radium; Survival Rate	2012
[Management of metastatic castration-resistant prostate cancer following docetaxel]. Bulletin du cancer, 2012, Volume: 99 Suppl 1 Topics: Abiraterone Acetate; Androgen Antagonists; Androstadienes; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Docetaxel; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids; Treatment Failure	2012
Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection. Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
Use of radionuclides in metastatic prostate cancer: pain relief and beyond. Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:3 Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium	2012
Management of docetaxel failures in metastatic castrate-resistant prostate cancer. The Urologic clinics of North America, 2012, Volume: 39, Issue:4 Topics: Androstenes; Androstenols; Antineoplastic Agents; Benzamides; Docetaxel; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Taxoids; Treatment Failure	2012
Radium-223 chloride: a new treatment option for metastatic castration-resistant prostate carcinoma. Drugs in R&D, 2012, Dec-01, Volume: 12, Issue:4 Topics: Antineoplastic Agents; Carcinoma; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radioisotopes; Radium	2012
New and emerging therapies for bone metastases in genitourinary cancers. European urology, 2013, Volume: 63, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; RANK Ligand; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urothelium; Zoledronic Acid	2013
[Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:1 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Denosumab; Disease-Free Survival; France; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Tissue Extracts; Treatment Outcome	2013
Radium-223 for the treatment of prostate cancer. Expert opinion on investigational drugs, 2013, Volume: 22, Issue:3 Topics: Bone Neoplasms; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Radium	2013
High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities? Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Oct-15, Volume: 12, Issue:20 Pt 2 Topics: Alpha Particles; Animals; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy, Adjuvant; Radium; Randomized Controlled Trials as Topic	2006
[Present and future in brachytherapy--from the discovery of radium to the 21st century]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9 Topics: Brachytherapy; Female; Humans; Male; Prostatic Neoplasms; Radiotherapy Dosage; Radium; Tongue Neoplasms; Uterine Neoplasms	1999

Trials

12 trial(s) available for radium and Prostatic Neoplasms

Article	Year
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS). BMC cancer, 2020, Jun-01, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Male; Middle Aged; Progression-Free Survival; Prostatic Neoplasms; Radioisotopes; Radiosurgery; Radium; Randomized Controlled Trials as Topic; Young Adult	2020
Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 08-15, Volume: 27, Issue:16 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Prostatic Neoplasms; Radium; Treatment Outcome	2021
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. The oncologist, 2021, Volume: 26, Issue:12 Topics: Aged; Benzamides; Castration; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium	2021
Alpha emitter radium-223 and survival in metastatic prostate cancer. The New England journal of medicine, 2013, Jul-18, Volume: 369, Issue:3 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Double-Blind Method; Humans; Isotopes; Kaplan-Meier Estimate; Male; Middle Aged; Prostatic Neoplasms; Radium	2013
New radiation therapy prolongs metastatic prostate cancer survival. ONS connect, 2013, Volume: 28, Issue:3 Topics: Humans; Male; Neoplasm Metastasis; Placebos; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate	2013
Radium-223 plus chemo shows clear OS benefit. Oncology (Williston Park, N.Y.), 2011, Nov-15, Volume: 25, Issue:12 Topics: Alpha Particles; Chemoradiotherapy; Humans; Male; Prostatic Neoplasms; Radium	2011
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Humans; Male; Pain; Palliative Care; Prostatic Neoplasms; Radium; Survival Analysis	2012
A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer. European urology, 2013, Volume: 63, Issue:2 Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Alpha Particles; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Drug Administration Schedule; Humans; Kallikreins; Male; Middle Aged; Pain Measurement; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome	2013
Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature review. BMJ case reports, 2012, Nov-01, Volume: 2012 Topics: Adenocarcinoma; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Drug Resistance, Neoplasm; Humans; Male; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2012
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-15, Volume: 11, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Alpha Particles; Bone Neoplasms; Breast Neoplasms; Diarrhea; Dose-Response Relationship, Radiation; Fatigue; Female; Follow-Up Studies; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Neutropenia; Pain; Prostatic Neoplasms; Radionuclide Imaging; Radium; Treatment Outcome; Vomiting	2005
[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2006, Volume: 50, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Treatment Outcome	2006
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. The Lancet. Oncology, 2007, Volume: 8, Issue:7 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Placebos; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radium; Survival Rate	2007

Other Studies

88 other study(ies) available for radium and Prostatic Neoplasms

Article	Year
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial. International journal of clinical oncology, 2019, Volume: 24, Issue:12 Topics: Abiraterone Acetate; Bone Density; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration. Current radiopharmaceuticals, 2020, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Compression Bandages; Exercise Therapy; Female; Humans; Lymphedema; Male; Prostatic Neoplasms; Radioisotopes; Radium	2020
Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization. Clinical genitourinary cancer, 2020, Volume: 18, Issue:3 Topics: Aged; Aged, 80 and over; Drug-Related Side Effects and Adverse Reactions; Follow-Up Studies; Global Health; Humans; Male; Middle Aged; Neoplasm Metastasis; Pharmacovigilance; Prognosis; Prostatic Neoplasms; Radium; Risk Assessment; Survival Rate; United States; United States Food and Drug Administration	2020
In situ Generated Current radiopharmaceuticals, 2020, Volume: 13, Issue:2 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Humans; Lead Radioisotopes; Ligands; Male; Mice; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Thorium	2020
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223. BMC cancer, 2020, Jun-29, Volume: 20, Issue:1 Topics: Animals; Bone Neoplasms; Brachytherapy; Cell Line, Tumor; Computer Simulation; Disease Progression; Humans; Intravital Microscopy; Male; Mice; Microscopy, Fluorescence; Models, Biological; Prostatic Neoplasms; Radiation Tolerance; Radium; Tibia; Xenograft Model Antitumor Assays	2020
Typical Acute Traumatic Fracture Healing in an 83-Year-Old Man Undergoing 223Ra Treatment for Prostatic Cancer Bone Metastases. Clinical nuclear medicine, 2020, Volume: 45, Issue:9 Topics: Aged, 80 and over; Bone Neoplasms; Fracture Healing; Humans; Male; Prostatic Neoplasms; Radium; Tibial Fractures	2020
[A Case of Prostate Adenocarcinoma Metastasis to the Bilateral Breasts]. Hinyokika kiyo. Acta urologica Japonica, 2021, Volume: 67, Issue:1 Topics: Adenocarcinoma; Aged; Breast Neoplasms; Humans; Male; Mastectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Radium	2021
Pretreatment PSA levels affects the completion rate of Ra-223 treatment. Scientific reports, 2021, 03-19, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radium; Treatment Outcome	2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 06-01, Volume: 27, Issue:11 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Exosomes; Extracellular Vesicles; Gene Expression; Gene Expression Profiling; Humans; Immune Checkpoint Proteins; Male; Mice; Prostatic Neoplasms; Radiopharmaceuticals; Radium; RNA; Survival Rate; Tumor Microenvironment	2021
Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2021, Volume: 38, Issue:1 Topics: Animals; Electroporation; Humans; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radium	2021
Radium-223 in patients with prostate specific antigen (PSA) progression and without clinical metastases following maximal local therapy: A pilot study. Urologic oncology, 2022, Volume: 40, Issue:1 Topics: Aged; Antineoplastic Agents; Disease Progression; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radium	2022
Radium Ra 223 Alpha Therapy for Prostate Cancer Bone Metastasis. Radiologic technology, 2021, Volume: 92, Issue:6 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2021
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy. Oncotarget, 2017, Jul-04, Volume: 8, Issue:27 Topics: Aged; Biomarkers; Blood Cell Count; Bone Neoplasms; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Off-Label Use; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radium; Single Photon Emission Computed Tomography Computed Tomography	2017
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer. Applied health economics and health policy, 2018, Volume: 16, Issue:1 Topics: Androstenes; Antineoplastic Agents; Benzamides; Cost-Benefit Analysis; Health Care Costs; Humans; Male; Markov Chains; Netherlands; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Quality-Adjusted Life Years; Radium; Treatment Failure	2018
Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Annals of nuclear medicine, 2018, Volume: 32, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone and Bones; Bone Neoplasms; Humans; Male; Middle Aged; Prostatic Neoplasms; Radium; Tumor Burden	2018
[Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice]. Lakartidningen, 2017, 11-06, Volume: 114 Topics: Androstenes; Antineoplastic Agents; Benzamides; Bevacizumab; Breast Neoplasms; Colorectal Neoplasms; Drug Utilization; Humans; Ipilimumab; Male; Melanoma; Neoplasms; Nitriles; Palliative Care; Phenylthiohydantoin; Pilot Projects; Prostatic Neoplasms; Radium; Registries; Survival Rate; Sweden; Withholding Treatment	2017
EMA guidance on radium-223 dichloride in prostate cancer. The Lancet. Oncology, 2018, Volume: 19, Issue:4 Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; European Union; Fractures, Bone; Humans; Male; Prednisone; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate	2018
Osteonecrosis of the Jaw in a Patient With Bone Metastatic Prostate Cancer After Long-term Bisphosphonate Treatment With Severe Deterioration Following Radium-223. Clinical genitourinary cancer, 2018, Volume: 16, Issue:5 Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Neoplasms; Diphosphonates; Disease Progression; Fatal Outcome; Humans; Male; Prostatic Neoplasms; Radium	2018
Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide. Experimental oncology, 2018, Volume: 40, Issue:2 Topics: Abiraterone Acetate; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Tomography, X-Ray Computed; Treatment Outcome	2018
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy. BMJ case reports, 2018, Jul-06, Volume: 2018 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Calcium Carbonate; Ergocalciferols; Humans; Hypocalcemia; Male; Middle Aged; Prostatic Neoplasms; Radioisotopes; Radium; Whole Body Imaging	2018
Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone. Journal of the National Cancer Institute, 2019, 10-01, Volume: 111, Issue:10 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Radiation; Humans; Male; Mice; Microscopy, Fluorescence, Multiphoton; Prostatic Neoplasms; Radium; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019
Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.'s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Ur European urology, 2019, Volume: 75, Issue:3 Topics: Abiraterone Acetate; Humans; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro. Biomaterials, 2019, Volume: 197 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Culture Techniques; Cell Proliferation; Docetaxel; Drug Screening Assays, Antitumor; Humans; Male; Mice, SCID; PC-3 Cells; Prostatic Neoplasms; Radium; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment	2019
Meaningful differences and validity for the NCCN/FACT-P Symptom Index: An analysis of the ALSYMPCA data. Cancer, 2019, 06-01, Volume: 125, Issue:11 Topics: Clinical Trials, Phase III as Topic; Humans; Male; Patient Reported Outcome Measures; Prostatic Neoplasms; Psychological Tests; Psychometrics; Quality of Life; Radioisotopes; Radium; Treatment Outcome	2019
Combination therapies in prostate cancer: proceed with caution. The Lancet. Oncology, 2019, Volume: 20, Issue:3 Topics: Abiraterone Acetate; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Assessment of the radiation absorbed dose produced by Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2019, Volume: 146 Topics: Actinium; Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Models, Biological; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Tumor Microenvironment	2019
Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response. Nuclear medicine communications, 2019, Volume: 40, Issue:6 Topics: Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium; Retrospective Studies; Treatment Outcome	2019
Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al's Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Uro European urology, 2019, Volume: 76, Issue:1 Topics: Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Induction and rejoining of DNA double-strand breaks in the lymphocytes of prostate cancer patients after radium-223 treatment as assessed by the γH2AX foci assay. Nuklearmedizin. Nuclear medicine, 2019, Volume: 58, Issue:5 Topics: Aged; Aged, 80 and over; DNA Breaks, Double-Stranded; DNA Repair; Histones; Humans; Lymphocytes; Male; Middle Aged; Prostatic Neoplasms; Radium	2019
FDA approves radiopharmaceutical for metastatic prostate cancer. Cancer discovery, 2013, Volume: 3, Issue:7 Topics: Bone Neoplasms; Clinical Trials as Topic; Drug Approval; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; United States; United States Food and Drug Administration	2013
Fighting prostate cancer with radium-223--not your Madame's isotope. The New England journal of medicine, 2013, Jul-18, Volume: 369, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical. Clinical nuclear medicine, 2013, Volume: 38, Issue:9 Topics: Aged; Bone Neoplasms; Drug Approval; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2013
Radium Ra 223 dichloride in castration-resistant prostate cancer. Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49, Issue:8 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate	2013
Radium - 223 (Xofigo) for prostate cancer. The Medical letter on drugs and therapeutics, 2013, Sep-30, Volume: 55, Issue:1426 Topics: Antineoplastic Agents; Bone Neoplasms; Drug Approval; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium; United States; United States Food and Drug Administration	2013
Prostate cancer: radium-223: a new treatment option for bone-metastatic CRPC. Nature reviews. Urology, 2013, Volume: 10, Issue:11 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Prostate cancer, version 1.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 2013, Dec-01, Volume: 11, Issue:12 Topics: Bone Neoplasms; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Radioisotopes; Radium; Recurrence	2013
US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Feb-01, Volume: 32, Issue:4 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Denosumab; Diphosphonates; Docetaxel; Drug Approval; Drugs, Investigational; Estramustine; Goserelin; Humans; Imidazoles; Male; Mitoxantrone; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids; Tissue Extracts; United States; United States Food and Drug Administration; Zoledronic Acid	2014
Advanced prostate cancer gets a new foe. The Johns Hopkins medical letter health after 50, 2013, Volume: 25, Issue:7 Topics: Antineoplastic Agents; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium	2013
Re: alpha emitter radium-223 and survival in metastatic prostate cancer. The Journal of urology, 2014, Volume: 191, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2014
To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Apr-10, Volume: 32, Issue:11 Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Castration; Denosumab; Diagnosis, Differential; Diphosphonates; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radium; RANK Ligand	2014
Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223. Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:4 Topics: Bone Neoplasms; Dose Fractionation, Radiation; Humans; Male; Pain Management; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Radium; Risk Assessment	2014
Radium-223 vs EBRT for multiple painful bone metastases: is less more? Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:4 Topics: Bone Neoplasms; Dose Fractionation, Radiation; Humans; Male; Pain Management; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Radium; Risk Assessment	2014
Radium-223: the newest option in metastatic castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2013, Volume: 11, Issue:12 Topics: Antineoplastic Agents; Castration; Humans; Male; Neoplasm Metastasis; Portraits as Topic; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2013
Radium-223 dichloride for the treatment of metastatic prostate cancer. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14 Topics: Bone and Bones; Bone Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic	2014
(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:2 Topics: Adult; Edetic Acid; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radium	2015
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223. Scandinavian journal of urology, 2015, Volume: 49, Issue:3 Topics: Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Male; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy; Radium; Tomography, X-Ray Computed; Treatment Outcome	2015
Targeted radionuclides for prostate cancer bone metastases. Urologic oncology, 2015, Volume: 33, Issue:1 Topics: Bone Neoplasms; Clinical Trials, Phase IV as Topic; Double-Blind Method; Humans; Male; Multicenter Studies as Topic; Neoplasm Metastasis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic	2015
Radium-223: Optimizing Treatment and Research of Osteoblastic Bone Metastasis. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:7 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2015
New developments in metastatic prostate cancer therapy. The Practitioner, 2015, Volume: 259, Issue:1781 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiotherapy; Radium; Risk Assessment; Taxoids; Therapies, Investigational; United Kingdom	2015
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Tomography, X-Ray Computed; Tumor Burden	2016
Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary. Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:4 Suppl 5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Prostatic Neoplasms; Radioisotopes; Radium; Treatment Outcome	2016
68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Antineoplastic Agents; Bone Neoplasms; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radium; Treatment Outcome	2016
Molecular Imaging in the Evaluation of 6 Doses of Ra-223 in High-Grade Prostate Cancer: Case Report. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Antigens, Surface; Clinical Trials, Phase III as Topic; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radium	2017
Radium-223 in prostate cancer: emitting the right signals. The Lancet. Oncology, 2016, Volume: 17, Issue:9 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2016
Prostate cancer: Radium-223 safe in combination. Nature reviews. Urology, 2016, Volume: 13, Issue:10 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2016
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:3 Topics: Aged; Bone Neoplasms; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radium; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2017
Exceptional Duration of Radium-223 in Prostate Cancer With a BRCA2 Mutation. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Bone Neoplasms; BRCA2 Protein; Humans; Male; Middle Aged; Mutation; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Treatment Outcome	2017
Diagnostic value of additional Nuklearmedizin. Nuclear medicine, 2017, Feb-14, Volume: 56, Issue:1 Topics: Aged; Aged, 80 and over; Carcinoma; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2017
Treatment of carcinoma of the prostate with radium. The Urologic and cutaneous review, 1948, Volume: 52, Issue:6 Topics: Carcinoma; Humans; Male; Prostatic Neoplasms; Radiotherapy; Radium	1948
Radiumpuncture of prostate cancer by the extravascular route of Millin. Bruxelles medical, 1948, Aug-01, Volume: 28, Issue:31 Topics: Humans; Male; Prostatic Neoplasms; Radium	1948
Potential synergistic implications for stromal-targeted radiopharmaceuticals in bone-metastatic prostate cancer. Asian journal of andrology, 2011, Volume: 13, Issue:3 Topics: Bone Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neoplastic Stem Cells; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Stromal Cells	2011
Abiraterone and increased survival in metastatic prostate cancer. The New England journal of medicine, 2011, 08-25, Volume: 365, Issue:8 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radium	2011
Radiation-based approaches for therapy and palliation of advanced prostate cancer. Current opinion in urology, 2012, Volume: 22, Issue:3 Topics: Alpha Particles; Bone Neoplasms; Dose Fractionation, Radiation; Evidence-Based Medicine; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Strontium Radioisotopes; Treatment Outcome	2012
Radium-223: down to the bone, and less is more. Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
An alpha edge? Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases. Clinical genitourinary cancer, 2013, Volume: 11, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Pain Management; Palliative Care; Proportional Hazards Models; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	2013
Dosimetry of 223Ra-chloride: dose to normal organs and tissues. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:2 Topics: Alpha Particles; Bone and Bones; Bone Marrow; Humans; Kinetics; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Radon; Risk; Time Factors; Tissue Distribution	2013
Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients. European urology, 2013, Volume: 63, Issue:2 Topics: Adenocarcinoma; Alpha Particles; Bone Neoplasms; Humans; Kallikreins; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2013
Intratumoral 224Ra-loaded wires spread alpha-emitters inside solid human tumors in athymic mice achieving tumor control. Anticancer research, 2012, Volume: 32, Issue:12 Topics: Alpha Particles; Animals; Brachytherapy; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Glioblastoma; Humans; Injections, Intralesional; Male; Melanoma; Mice; Mice, Nude; Neoplasms; Prostatic Neoplasms; Radium; Random Allocation; Thorium; Xenograft Model Antitumor Assays	2012
Three unusual cases of prostatic malignancy: adenocarcinoma with mucus cells; malignant lymphoma; leiomyosarcoma. The Journal of urology, 1953, Volume: 70, Issue:2 Topics: Adenocarcinoma; Humans; Leiomyosarcoma; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mucus; Prostatic Neoplasms; Radiotherapy; Radium	1953
[Ischio-rectal implantation of radium needles in certain cases of cancer of the prostate]. Bordeaux chirurgical, 1955, Volume: 2 Topics: Humans; Male; Needles; Neoplasms; Prostatic Neoplasms; Radium	1955
[Radium therapy of prostatic cancer]. Urologia polska, 1956, Volume: 9 Topics: Humans; Male; Prostatic Neoplasms; Radium	1956
[2 New therapeutics in cancer of the prostate]. The Journal of the International College of Surgeons, 1957, Volume: 28, Issue:5 Pt 1 Topics: Coal Tar; Estrogens; Humans; Male; Neoplasms; Prostatic Neoplasms; Radium	1957
A panel discussion of radioisotope therapy. Journal. Iowa State Medical Society, 1959, Volume: 49 Topics: Gold Radioisotopes; Humans; Hyperthyroidism; Iodine; Iodine Radioisotopes; Male; Prostatic Neoplasms; Radioisotopes; Radium; Thyroid Function Tests; Thyroid Gland	1959
[Where we stand in the treatment of prostate cancer]. Le Scalpel, 1963, Mar-16, Volume: 116 Topics: Humans; Male; Prostatic Neoplasms; Radium	1963
The results of radium treatment of cancer of the uterine cervix with special reference to glandular and stump cancer. The Journal of obstetrics and gynaecology of the British Empire, 1955, Volume: 62, Issue:3 Topics: Cervix Uteri; Female; Humans; Male; Neoplasms; Precancerous Conditions; Prostatic Neoplasms; Radium; Soft Tissue Neoplasms; Uterine Cervical Neoplasms	1955
[Reports from the radium clinics: prostatic cancer]. Ugeskrift for laeger, 1951, May-10, Volume: 113, Issue:19 Topics: Humans; Male; Prostate; Prostatic Neoplasms; Radium	1951
Radium-223 for men with hormone-refractory prostate cancer and bone metastases. The Lancet. Oncology, 2007, Volume: 8, Issue:7 Topics: Alkaline Phosphatase; Bone Neoplasms; Drug Resistance, Neoplasm; Humans; Male; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radium	2007
A new radiumpuncture technique for prostate cancer, the Millin way. La Presse medicale, 1949, Jun-11, Volume: 57, Issue:38 Topics: Humans; Male; Prostatic Neoplasms; Radium	1949
[Treatment of prostatic cancer with radiotherapy]. Acta urologica Belgica, 1980, Volume: 48, Issue:1 Topics: Humans; Lymph Nodes; Male; Neoplasm Staging; Physical Therapy Modalities; Prostatic Neoplasms; Radium	1980
Radiation therapy in the management of carcinoma of the prostate. Current problems in cancer, 1976, Volume: 1, Issue:5 Topics: Adenocarcinoma; Gynecomastia; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Neoplasms; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy; Radium; Urethral Stricture; Urinary Incontinence	1976
[10-year statistics of cobalt 60 radiotherapy for carcinoma in private practice]. Strahlentherapie, 1972, Volume: 144, Issue:5 Topics: Adult; Age Factors; Aged; Bone Neoplasms; Breast Neoplasms; Bronchial Neoplasms; Cobalt Isotopes; Esophageal Neoplasms; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Radium; Skin Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms	1972
It takes two to talk about prostate cancer: a qualitative assessment of African American men's and women's cancer communication practices and recommendations. American journal of men's health, 2012, Volume: 6, Issue:6 Topics: Adult; Aged; Attitude to Health; Black People; Communication; Communication Barriers; Digital Rectal Examination; Female; Focus Groups; Health Education; Health Promotion; Humans; Information Seeking Behavior; Interpersonal Relations; Male; Mass Screening; Men; Middle Aged; Physician-Patient Relations; Prostatic Neoplasms; Radio; Religion; South Carolina; Spouses; Women; Workplace; Young Adult	2012
DIAGNOSIS OF BONE METASTASIS BY PHOTOSCANNING WITH STRONTIUM 85. JAMA, 1964, Apr-06, Volume: 188 Topics: Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Humans; Male; Neoplasm Metastasis; Neoplasms; Prostatic Neoplasms; Radio; Radioisotopes; Radionuclide Imaging; Strontium; Strontium Isotopes	1964
Tough ads set up prostate exams. Profiles in healthcare marketing, 1991, Issue:44 Topics: Aged; Hospital Bed Capacity, 100 to 299; Humans; Male; Marketing of Health Services; Mass Screening; Middle Aged; Prostatic Neoplasms; Radio; South Carolina	1991